Lectin-like oxidized LDL receptor1 antibodies and methods of use
摘要
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as "LOX-1"), and pharmaceutical compositions and methods of treatment comprising the same.
申请公布号
AU2014281294(A1)
申请公布日期
2015.12.24
申请号
AU20140281294
申请日期
2014.06.20
申请人
NOVARTIS AG
发明人
DOLE, WILLIAM;TRAUGER, JOHN;TANG, YUTING;NEUGEBAUER, JULIA;SCHMID, ANNIKA;HELDWEIN, KURT;BROGDON, JENNIFER
